Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Further, having these genetic variants increases the risk of a person having faster-progressing ALS (amyotrophic lateral ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Minneapolis: According to a study, a class of diabetes medications may be linked ... diseases like dementia and Parkinson's disease are common and the number of cases is growing as the population ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...

A class of drugs for diabetes may be associated ... "We know that these neurodegenerative diseases like dementia and Parkinson's disease are common and the number of cases is growing as the ...

It could be a medical condition called essential tremor, and a new study by Singapore’s National Neuroscience Institute has ...

A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study ...